Publication | Closed Access

Agomelatine treatment corrects impaired sleep-wake cycle and sleep architecture and increases MT1 receptor as well as BDNF expression in the hippocampus during the subjective light phase of rats exposed to chronic constant light

OptogeneticsSleepBdnf ExpressionAlertnessSleep DisorderChronobiologyNeurophysiologyMedicinePhysiologyNeuropharmacologySleep ArchitectureSocial SciencesNeuroscienceChronic Constant LightInsomniaCircadian RhythmSleep DeprivationMelatonin